# Microvascular Angina Intervention With Compound Danshen Dripping Pill (MAIDS)

> **NCT06092736** · PHASE4 · RECRUITING · sponsor: **Qilu Hospital of Shandong University** · enrollment: 100 (estimated)

## Conditions studied

- Microvascular Angina

## Interventions

- **DRUG:** Compound Danshen Dropping Pills
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06092736
- **Lead sponsor:** Qilu Hospital of Shandong University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-12-18
- **Primary completion:** 2027-06-30
- **Final completion:** 2028-06-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06092736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06092736, "Microvascular Angina Intervention With Compound Danshen Dripping Pill (MAIDS)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06092736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*